Molecular Medicines for Cancer

Section I: Nanotechnology-Based Approaches to Target Cancer 1. Nanomedicines for Cancer 2. Effect of Nanocarrier Size/Surface on Molecular Targeting in Cancer 3. Nanocarrier Systems for Anticancer Drug Delivery at the Subcellular Level 4. Chemo-Resistance Reversal Using Nanomedicines 5. Multifunctional Dendrimers as Cancer Nanomedicines: Peptide-Based Targeting 6. Targeting the Tumor Microenvironment 7. Novel Nanoparticulate Drug Delivery Systems for Active Ingredients of Traditional Chinese Medicine in Cancer Therapy Section II: Imaging Technologies in Cancer 8. Noninvasive Imaging in Clinical Oncology: A Testimony of Current Modalities and a Glimpse into the Future 9. Multifunctional Nanocarriers as Theranostic Systems for Targeting Cancer 10. Emerging Nanotechnologies for Cancer Immunodiagnosis and Cancer Immunotherapies Section III: Oligonucleotides and Gene-Based Therapies 11. Nucleic Acid Nanotherapeutics 12. Long Non-Coding RNA and Cancer 13. miRNA Therapeutics to Target Multiple Molecular Pathways: Current Status, Challenges, and Future Prospects 14. Alliance of Lipids with siRNA: Opportunities and Challenges for RNAi Therapy 15. Lipid Nanocarriers for RNAi-Based Cancer Therapy 16. Advancements in Polymeric Systems for Nucleic Acid Delivery 17. Self-Assembling Programmable RNA Nanoparticles: From Design and Characterization to Use as an siRNA Delivery Platform 18. DNA Repair and Epigenetics in Cancer 19. Genomic Engineering Utilizing the CRISPR/Cas System and Its Application in Cancer

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Tecnologia farmacêutica
• Biologia, ciências da vida
• Ciência ambiental, engenharia e tecnologia
• Nanotecnologia

Delivery Systems;EPR Effect;Nanotechnology in cancer therapeutics;siRNA Delivery;Anticancer agents;Cancer Stem Cells;Cancer biology;Transfection Efficiency;Oligonucleotide and gene based therapies;Nucleic Acid Delivery;Nanotechnology based approaches for molecular targeting of cancer;EVs;Chemo-resistance reversal using nanomedicines;CPP;Anupama Mittal;Tumor Suppressor Gene PTEN;Ram I. Mahato;Gene Delivery;Jiasheng Tu;Quantum Dots;Birendra Chaurasiya;RNA NPs;Yanan Li;Endosomal Escape;Eupa Ray;Antitumor Immune Response;Ankur Sharma;Drug Release;Kalpesh Vaghasiya;DNA Methylation;Rahul Kumar Verma;Cancer Cells;Reza Mahjub;EGFP;Shyh-Dar Li;LHRH Receptor;Can Sarisozen;Tumor Suppressor Gene;Jiayi Pan;Drug Delivery;Vladimir P. Torchilin;RNAi Therapeutics;Chie Kojima;HBV;Andrew Cannon;Car T-cells;Suprit Gupta;CRISPR Array;Rakesh Bhatia;Christopher Thompson;Brad Hall;Surinder K. Batra;Sushil Kumar;Meiwan Chen;Zhaopei Guo;Aniketh Bishnu;Abhilash Deo;Ajit Dhadve;Bhushan Thakur;Souvik Mukherjee;Pritha Ray;Gaurav Pandey;Rashmi Chaudhari;Vinod Kumar Gupta;Abhijeet Joshi;Amy M. Wen;Nicole F. Steinmetz;Sourabh Shukla;Siddharth Jhunjhunwala;Mateja M. Jelen;Lihui Zhu;Guofeng Cheng;Anu Puri;Mathias Viard;Paul Zakrevsky;Lorena Parlea;Krishna Pal Singh;Bruce A. Shapiro;Ranganayaki Muralidharan;Anish Babu;Narsireddy Amreddy;Janani Panneerselvam;Meghna Mehta;Anupama Munshi;Rajagopal Ramesh;Vinayak Sadashiv Mharugde;Sudeep Pukale;Saurabh Sharma;Brandon Roark;Morgan Chandler;Faye Walker;Lucia Milanova;Viktor Viglasky;Martin Panigaj;Kirill A. Afonin;Loredana Zocchi;Claudia A. Benavente;Amit Kumar Chaudhary;Rajan Sharma Bhattarai;Chalet Tan;Channabasavaiah B. Gurumurthy